127 related articles for article (PubMed ID: 16109615)
1. Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples?
Steinbach D; Friedrich J; Dawczynski K; Furchtbar S; Gruhn B; Wittig S; Zintl F; Sauerbrey A
Leuk Lymphoma; 2005 Sep; 46(9):1357-63. PubMed ID: 16109615
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ
Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662
[TBL] [Abstract][Full Text] [Related]
3. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
[TBL] [Abstract][Full Text] [Related]
4. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
Ho MM; Hogge DE; Ling V
Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of a MDR1 transcript for prediction of drug resistance in acute leukemia.
Fujimaki S; Funato T; Harigae H; Fujiwara J; Kameoka J; Meguro K; Kaku M; Sasaki T
Clin Chem; 2002 Jun; 48(6 Pt 1):811-7. PubMed ID: 12028995
[TBL] [Abstract][Full Text] [Related]
7. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.
Steinbach D; Wittig S; Cario G; Viehmann S; Mueller A; Gruhn B; Haefer R; Zintl F; Sauerbrey A
Blood; 2003 Dec; 102(13):4493-8. PubMed ID: 12816874
[TBL] [Abstract][Full Text] [Related]
8. ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia.
Steinbach D; Gillet JP; Sauerbrey A; Gruhn B; Dawczynski K; Bertholet V; de Longueville F; Zintl F; Remacle J; Efferth T
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4357-63. PubMed ID: 16857811
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P
Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944
[TBL] [Abstract][Full Text] [Related]
10. The role of drug efflux pumps in acute myeloid leukemia.
van der Kolk DM; de Vries EG; Müller M; Vellenga E
Leuk Lymphoma; 2002 Apr; 43(4):685-701. PubMed ID: 12153153
[TBL] [Abstract][Full Text] [Related]
11. Response to chemotherapy and expression of the genes encoding the multidrug resistance-associated proteins MRP2, MRP3, MRP4, MRP5, and SMRP in childhood acute myeloid leukemia.
Steinbach D; Lengemann J; Voigt A; Hermann J; Zintl F; Sauerbrey A
Clin Cancer Res; 2003 Mar; 9(3):1083-6. PubMed ID: 12631611
[TBL] [Abstract][Full Text] [Related]
12. ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers.
Varatharajan S; Abraham A; Karathedath S; Ganesan S; Lakshmi KM; Arthur N; Srivastava VM; George B; Srivastava A; Mathews V; Balasubramanian P
Pharmacogenomics; 2017 Feb; 18(3):235-244. PubMed ID: 28112576
[TBL] [Abstract][Full Text] [Related]
13. Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance.
Den Boer ML; Kapaun P; Pieters R; Kazemier KM; Janka-Schaub GE; Veerman AJ
Br J Haematol; 1999 Jun; 105(4):876-82. PubMed ID: 10554796
[TBL] [Abstract][Full Text] [Related]
14. Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status.
Bracht K; Kiefer T; Dölken G; Bednarski PJ
J Cancer Res Clin Oncol; 2007 Dec; 133(12):957-67. PubMed ID: 17562080
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia.
Kim HP; Bernard L; Berkowitz J; Nitta J; Hogge DE
Cytometry B Clin Cytom; 2012 Sep; 82(5):283-94. PubMed ID: 22508650
[TBL] [Abstract][Full Text] [Related]
16. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
17. Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.
Zwaan CM; Kaspers GJ; Pieters R; Ramakers-Van Woerden NL; den Boer ML; Wünsche R; Rottier MM; Hählen K; van Wering ER; Janka-Schaub GE; Creutzig U; Veerman AJ
Blood; 2000 Oct; 96(8):2879-86. PubMed ID: 11023525
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes.
Hauswald S; Duque-Afonso J; Wagner MM; Schertl FM; Lübbert M; Peschel C; Keller U; Licht T
Clin Cancer Res; 2009 Jun; 15(11):3705-15. PubMed ID: 19458058
[TBL] [Abstract][Full Text] [Related]
19. Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin.
Aberuyi N; Rahgozar S; Pourabutaleb E; Ghaedi K
Curr Res Transl Med; 2021 Jan; 69(1):103269. PubMed ID: 33071214
[TBL] [Abstract][Full Text] [Related]
20. Expression of ABC-transport proteins in canine mammary cancer: consequences for chemotherapy.
Honscha KU; Schirmer A; Reischauer A; Schoon HA; Einspanier A; Gäbel G
Reprod Domest Anim; 2009 Jul; 44 Suppl 2():218-23. PubMed ID: 19754573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]